Pharmaceutical Contract Manufacturing Competitor Analysis Report - Global Forecast to 2026
The Global Pharmaceutical Contract Manufacturing Market size was estimated at USD 89.91 Billion in 2020 and expected to reach USD 97.17 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 8.33% to reach USD 145.35 Billion by 2026.
FPNV Positioning Matrix: The FPNV Positioning Matrix evaluates and categorizes the vendors in the Pharmaceutical Contract Manufacturing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
"Pfizer Inc. scored highest as a forefront vendor in FPNV Positioning Matrix for Pharmaceutical Contract Manufacturing Market"
Forefront are rated highly by the users for product satisfaction and have substantially good business strategy scores. F-Forefront include Pfizer Inc., Danaher Corporation, AbbVie, Inc., Evonik Industries AG, C. H. Boehringer Sohn AG & Co. KG, Thermo Fisher Scientific Inc., Lonza Group, Catalent, Inc., Baxter International Inc., and Siegfried Holding AG.
"Recipharm AB scored highest as a pathfinder and expected to the upcoming forefront in next couple of years"
Pathfinder have significant product satisfaction ratings but somehow lack business strategy as compared to forefronts and vitals. P-Pathfinder include Recipharm AB, Dr. Reddy’s Laboratories Ltd., Serum Institute of India Ltd., Almac Group, AMRI Global, Vetter Pharma International GMBH, Aenova Group GmbH, Cambrex Corporation, and Famar Health Care Services.
"Sycon Healthcare named as an upcoming vendor to watch in Pharmaceutical Contract Manufacturing Market"
Niche solutions cater to the need of comparatively smaller segment of the overall market. They do not have the business strategy of the Forefront. They may have been rated positively on product satisfaction but have not yet received enough reviews to validate them. N-Niche include Sycon Healthcare, Biozoc Inc., Jubilant Life Sciences Limited, Pidolma Healthcare, and Kryptochem Medicament Pvt. Ltd..
"Innovative offerings by Amgen Inc. expected to increase its product satisfaction level for Pharmaceutical Contract Manufacturing Market in upcoming years"
Vital have comparatively good business strategy but have not yet achieved the business strategy of the Forefront. However, they have low product satisfaction ratings. V-Vital include Amgen Inc., Fareva, and Mitsubishi Tanabe Pharma Corporation.
Market Share Analysis: The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario: The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles: The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Pharmaceutical Contract Manufacturing Market, including AbbVie, Inc., Aenova Group GmbH, Almac Group, Amgen Inc., AMRI Global, Baxter International Inc., Biozoc Inc., C. H. Boehringer Sohn AG & Co. KG, Cambrex Corporation, Catalent, Inc., Danaher Corporation, Dr. Reddy’s Laboratories Ltd., Evonik Industries AG, Famar Health Care Services, Fareva, Jubilant Life Sciences Limited, Kryptochem Medicament Pvt. Ltd., Lonza Group, Mitsubishi Tanabe Pharma Corporation, Pfizer Inc., Pidolma Healthcare, Recipharm AB, Serum Institute of India Ltd., Siegfried Holding AG, Sycon Healthcare, Thermo Fisher Scientific Inc., and Vetter Pharma International GMBH.
Our reports have been used by over 10K customers, including:
The global bio-based platform chemicals market is expected to exhibit strong growth during 2021-2026. Bio-based platform chemicals refer to the group of chemical compounds manufactured by breaking down and processing biological materials. Some of the commonly used bio-based platform chemicals include bio-glycerol, glutamic...
120 pages •
By Infiniti Research Limited
• Nov 2021
Global Papaya Market 2022-2026 The analyst has been monitoring the papaya market and it is poised to grow by 2511.93 thousand tons during 2022-2026, progressing at a CAGR of 3.29% during the forecast period. Our report on the papaya market provides a holistic analysis, market size and forecast, trends, growth drivers, and...
The global automated liquid handlers market was valued at USD 685.96 million in 2020, and it is expected to reach USD 939.92 million by 2026, with an estimated CAGR of 5.39%, from 2021 to 2026. Key Highlights - The flexibility and adaptability of automation systems made automated liquid handlers’ equipment widely...
KEY FINDINGS The global aseptic pharma processing & packaging equipment market is set to progress with a CAGR of 7.12% during the forecasted years of 2021 to 2028. The market growth of the country is associated with key drivers such as the increasing demand for generics and biopharmaceuticals markets, the rising adoption...
The Global Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2021 report. This report provides details of the latest option and evaluation agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and updated, the report provides details...
The Global Biosimilars Partnering Terms and Agreements 2010 to 2021 report provides an understanding and access to the Biosimilars partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in Biosimilars partnering deals Disclosed headlines, upfronts, milestones and royalties...
The Global Microbiome Partnering Terms and Agreements 2010 to 2021 report provides an understanding and access to the Microbiome partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in Microbiome partnering deals Disclosed headlines, upfronts, milestones and royalties by...
The global curcumin market grew at a CAGR of around 9% during 2015-2020. Looking forward, the analyst expects the market to exhibit strong growth during the next five years. Curcumin is a yellow-colored, naturally occurring bioactive compound commercially extracted from the dried rhizome of the turmeric plant....
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.